Equities
Health CareMedical Equipment and Services
  • Price (USD)133.67
  • Today's Change-0.19 / -0.14%
  • Shares traded69.00
  • 1 Year change+23.23%
  • Beta1.0617
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.

  • Revenue in USD (TTM)6.50bn
  • Net income in USD1.41bn
  • Incorporated1999
  • Employees17.40k
  • Location
    Agilent Technologies Inc5301 Stevens Creek BlvdSANTA CLARA 95051United StatesUSA
  • Phone+1 (408) 345-8886
  • Fax+1 (408) 345-8474
  • Websitehttps://www.agilent.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
A:NYQ since
announced
Transaction
value
Sigsense Technologies IncDeal completed29 Jul 202429 Jul 2024Deal completed-2.66%--
BioVectra IncDeal completed22 Jul 202422 Jul 2024Deal completed1.43%925.00m
Data delayed at least 15 minutes, as of Nov 13 2024.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cooper Companies Inc3.80bn359.30m20.31bn15.00k56.802.5627.605.341.801.8019.0239.800.31961.705.56253,606.703.0210.063.2911.3466.3665.549.4529.001.185.460.24930.34698.617.24-23.74-3.6615.180.00
Zimmer Biomet Holdings Inc7.60bn1.08bn21.89bn18.00k20.941.7710.632.885.255.2536.8762.000.35380.91365.38421,972.205.052.215.822.5271.7871.2514.287.280.69877.520.342538.906.55-1.40252.86--9.440.00
Steris PLC5.12bn602.62m21.96bn18.18k36.663.3319.834.296.084.3851.6266.800.47583.865.49281,655.405.625.196.105.6843.0143.6411.8110.971.558.290.252836.5613.2813.06-1.0712.6713.698.83
Waters Corp2.91bn622.64m22.91bn7.90k36.8114.2928.127.8810.4810.4848.8927.000.6452.204.47367,740.1013.8219.7716.7225.2959.7358.4521.4323.381.3810.110.53250.00-0.52294.09-9.261.534.72--
Illumina Inc4.39bn-1.58bn23.41bn10.59k--11.05--5.33-10.00-10.0027.6113.360.54412.666.17414,542.00-19.63-6.20-23.16-7.2863.9466.39-36.08-15.481.8538.440.4834---1.756.2173.64---7.91--
West Pharmaceutical Services Inc.2.88bn499.60m23.73bn10.60k48.558.6337.428.256.756.7538.8637.960.77434.505.51271,358.5013.0215.6115.1618.6534.8738.0616.8118.472.23--0.069510.692.1811.432.2823.7628.166.20
DexCom Inc3.95bn680.80m29.04bn9.60k45.3814.6732.517.341.641.649.525.070.61072.764.42411,875.0010.518.3014.2810.5062.1065.9017.2214.142.12--0.55790.0024.4928.5658.70--28.66--
IDEXX Laboratories, Inc.3.84bn866.24m34.89bn11.00k41.1121.6035.179.0810.3610.3646.0019.721.193.857.14349,528.8026.9128.0038.8643.4960.7258.7422.5321.351.0359.100.35070.008.7210.5924.4417.391.68--
Resmed Inc4.81bn1.11bn36.29bn9.98k32.776.9828.147.557.547.5432.5935.390.68862.176.08481,711.9015.9414.2418.1116.5357.6756.8523.1520.351.9144.710.115432.6210.9512.4413.7519.988.235.34
Veeva Systems Inc2.57bn615.26m38.30bn7.17k61.377.3858.7614.883.853.8515.6932.040.4453--6.27358,846.8010.6511.9712.9715.3673.3572.0023.9123.74----0.000.009.6822.357.7918.0021.68--
Agilent Technologies Inc6.50bn1.41bn38.41bn17.40k27.806.5123.105.914.814.8122.1420.530.59962.875.06358,950.3013.0411.0016.1313.2554.7553.2921.7518.011.3755.860.331921.46-0.2196.82-1.127.3910.988.86
GE HealthCare Technologies Inc19.56bn1.68bn38.80bn51.00k23.264.6616.771.983.653.6542.6318.200.59065.404.41383,490.205.22--6.97--41.33--8.84--0.9825.670.5478--6.60---26.82------
Edwards Lifesciences Corp5.62bn1.43bn38.81bn19.80k27.794.0724.856.902.376.939.3216.180.50321.127.72283,904.0012.7616.6314.9819.1278.6376.7125.3524.842.89--0.05850.0011.5610.03-7.8513.701.96--
Cencora Inc293.96bn1.51bn49.02bn42.00k33.1562.3118.600.16687.517.511,467.703.994.5315.5912.44--2.341.1211.514.833.353.250.51680.25560.529119.370.84865.3812.1210.36-13.5313.029.454.98
Data as of Nov 13 2024. Currency figures normalised to Agilent Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

39.73%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202433.45m11.64%
BlackRock Fund Advisorsas of 30 Jun 202415.35m5.34%
Massachusetts Financial Services Co.as of 30 Jun 202415.06m5.24%
SSgA Funds Management, Inc.as of 30 Jun 202412.66m4.41%
T. Rowe Price Investment Management, Inc.as of 30 Jun 20249.25m3.22%
Wellington Management Co. LLPas of 30 Jun 20248.67m3.02%
Geode Capital Management LLCas of 30 Jun 20246.92m2.41%
Pictet Asset Management SAas of 30 Jun 20245.34m1.86%
State Farm Investment Management Corp.as of 30 Jun 20243.83m1.33%
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 20243.63m1.26%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.